Biogen (BIIB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BIIB Biogen

Watchlist

156.320
-0.140-0.09%

Close Dec 10 16:00 ET

156.460
+0.140+0.09%

Pre 09:04 ET

22.78BMarket Cap14.13P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Biogen Reinstated With a Neutral at BofA
Yahoo Finance07:10 ET
BofA Restarts Coverage of 11 Large-cap Biopharmas
Seeking Alpha17:01 ET
Market Falls Wednesday, but Googles Chip Impresses | WST
Kevin Travers16:19 ET
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Kevin TraversDec 10 10:51 ET
B of A Securities Reinstates Neutral on Biogen, Announces $178 Price Target
BenzingaDec 10 07:38 ET · Ratings
Insider Sale: Head of Development of $BIIB (BIIB) Sells 110 Shares
Quiver QuantitativeDec 9 17:02 ET

Comments

Moomoo News Global

Dec 4 08:19

Columns Which Stocks Could Join the Nasdaq 100? Palantir and MicroStrategy Lead the List

The annual adjustment of the $NASDAQ 100 Index (.NDX.US)$ components will be announced next Friday (December 13). According to the market capitalization ranking, in addition to the strong performers $Palantir (PLTR.US)$ and $MicroStrategy (MSTR.US)$, $Equinix Inc (EQIX.US)$, and $Coinbase (COIN.US)$ are also expected to become new members.
On the other hand, six companies, headed by $Moderna (MRNA.US)$, $Super Micro Computer (SMCI.US)$, ...

Nasdaq hits new highs, adjustment looms: Who will stand out?

J-Eazy

Nov 15 13:08

garabage

this stock is 🗑️
$Biogen (BIIB.US)$

QMengColdJoke

Nov 14 10:04

? you just saved world?

$Biogen (BIIB.US)$

Movers and Shakers

Oct 30 07:28

Columns Today's Pre-Market Movers and Top Ratings | GOOGL, AMD, V, LLY and More

Morning Movers
Gapping up
$Alphabet-A (GOOGL.US)$ stock rose 6.3% following third-quarter results that exceeded expectations, with a notable increase in advertising revenue, which alleviated concerns over competition from AI-driven search products.
$Biogen (BIIB.US)$ stock increased 1.2% after the biotech company raised its annual earnings forecast and reported third-quarter earnings that surpassed both top and bottom line expe...